An Open-Label Pilot Study of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Endoscopic Postoperative Recurrence in Crohn’s Disease

Publisher： Karger

E-ISSN： 1421-9867|68|2-3|63-70

ISSN： 0012-2823

Source： Digestion, Vol.68, Iss.2-3, 2004-01, pp. : 63-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study

By James Dustin   Seo Da   Chen Jiajing   Vemulapalli Caroline   Stone Christian  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1806-1810

Springer Publishing Company

Access to resources Recommend Favorite

Serum Granulocyte Colony-Stimulating Factor and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 2, Iss. 1, 2012-08 ,pp. : 353-360

Karger

Access to resources Recommend Favorite

Treatment of Postoperative Crohn’s Disease

By  

Digestion, Vol. 71, Iss. 1, 2005-03 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

Granulocyte Colony-Stimulating Factor Potentiated Severe Atypical Vincristine-Induced Neuropathy

By  

Medical Principles and Practice, Vol. 7, Iss. 1, 1998-04 ,pp. : 68-73

Karger

Access to resources Recommend Favorite

Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn’s Disease

By Chermesh Irit   Tamir Ada   Reshef Ron   Chowers Yehuda   Suissa Alain   Katz Dalia   Gelber Moshe   Halpern Zamir   Bengmark Stig   Eliakim Rami  

Digestive Diseases and Sciences, Vol. 52, Iss. 2, 2007-02 ,pp. : 385-389

Springer Publishing Company

Access to resources Recommend Favorite